PIN1 and pulmonary arterial hypertension: Since our in vitro data suggest that inhibiting Pin1 with juglone has therapeutic potential in the treatment of PAH, we induced PAH in rats using the MCT + Shunt model and treated them with juglone (1 mg/kg/day) orally in drinking water from 21 days onwards after the induction of PAH (Fig. 3A).